|Videos|April 27, 2022

Addressing the Shortage of Medical Laboratory Professionals

These paramount medical personnel behind the scenes are facing staffing challenges that could be bordering on a national crisis in public health.


The average person will receive 42 laboratory tests in their lifetime. According to the American Clinical Laboratory Association, there are more than 7 billion clinical lab tests performed in the US annually. Add to this, the millions of COVID-19 tests administered over the last 2 years, and the strain this has put on medical laboratory professionals is immense. Although this profession is responsible for all the lab tests administered, there is a shortage in the number of professionals working in the field, and the future predictions for new people entering laboratory sciences makes it more dire.

“With the projected increases in the need for medical laboratory professionals, and the current high vacancy rates, the profession is suffering from a workforce shortage that is approaching crisis levels for medical laboratory technicians, medical laboratory scientists, histotechnicians and histotechnologists,” the American Society for Clinical Laboratory Science (ASCLS) wrote on their website.

ASCLS says some of the reasons for the shortages include: retirements, an increased demand for lab services, changes in the practice of clinical laboratory science due to technology advances, and vacancies that exceed the number of graduates.

Although a strong need for these essential medical personnel remains, there are some inherent challenges to finding the next generation of medical laboratory professionals. For starters, as this profession is not public facing, there is a lack of awareness about the field and this lack of knowledge hinders potential recruitment of high school or college students who might be science-oriented, explained Rodney E. Rohde, PhD, MS, SM(ASCP)CM, SVCM, MBCM, FACSc regents’ professor, Texas State University, university distinguished chair & professor, Clinical Laboratory Science.

“We are not dealing with patients like a nurse or physician, and so your aunt, your grandmother, even high school teachers and guidance counselors—or for that matter college advisors—do not always understand that our major, medical laboratory science, can be found at the associates level; you can find it in a four year degree like mine at Texas State University; there are various masters programs; and now we have 3 really interesting doctorate clinical laboratory science programs at Rutgers, UT in Galveston, and University of Kansas Medical Center,” Rohde said.

This week marks National Medical Laboratory Professionals Week across the US, and with it an understanding of the value of this honored profession.

“We want to celebrate,” Rohde stated about this awareness week. "…[we want] to shine that light on awareness and visibility on this profession and work towards really bringing in more high school students, transfer students, community college students, and anybody out there that is interested in diagnostic detective work to really give our major a look.”

In the first of a 2-part interview, Contagion spoke with Rohde about the importance of this week and celebrating Medical Laboratory Professionals, the shortages in the field, and some of the strategies to alleviate this major issue.

For those interested in learning more about National Medical Laboratory Professionals Week, check out the American Society of Microbiology website for resources and events.


Related to this article

Cefiderocol Continues to Show Activity Against Resistant Gram-Negative Infections
Shionogi data presented at IDWeek 2026 demonstrated a 76.7% clinical response with cefiderocol in carbapenem-resistant respiratory infections and high in vitro activity against resistant P aeruginosa VAP isolates. Christine Slover, PharmD, vice president, Infectious Diseases US Medical Affairs, Shionogi, offers insights on the data as well as clinical considerations for providers when weighing the antibiotic for patients.
Household Contacts Drive Most Hepatitis B Exposures in Young Children
Karen B. Jacobson, MD, MPH, of Kaiser Permanente Northern California, presented data at IDWeek 2026 showing 58.2% of children younger than five years exposed to active hepatitis B in the home were exposed by someone other than their birth mother, a risk maternal screening alone would miss under the CDC’s revised birth dose recommendation.
Inhaled Amikacin Shows Low Resistance Rates in MAC Lung Disease in ENCORE
In the phase 3b ENCORE trial, adding amikacin liposome inhalation suspension (ALIS) to azithromycin and ethambutol significantly improved culture conversion in newly diagnosed MAC lung disease, while treatment-emergent amikacin (2.2%) and macrolide (1.1%) resistance stayed rare. Kevin Winthrop, MD, provides insights around the study.